Variant report
Variant | nsv614887 |
---|---|
Chromosome Location | chr9:96470473-96471340 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs561916465 | chr9:96470489-96470490 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs184040849 | chr9:96470531-96470532 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs571765971 | chr9:96470551-96470552 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs571372258 | chr9:96470559-96470560 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs538868332 | chr9:96470591-96470592 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs144105695 | chr9:96470596-96470597 | Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs189498006 | chr9:96470624-96470625 | Enhancers Weak transcription Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs180999808 | chr9:96470687-96470688 | Enhancers Weak transcription Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
9 | rs558401891 | chr9:96470782-96470783 | Enhancers Weak transcription Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs148686394 | chr9:96470794-96470795 | Enhancers Weak transcription Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs142076355 | chr9:96470839-96470840 | Flanking Active TSS Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs74531522 | chr9:96470853-96470854 | Flanking Active TSS Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs184331754 | chr9:96470883-96470884 | Flanking Active TSS Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs139209547 | chr9:96470886-96470887 | Flanking Active TSS Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs529232965 | chr9:96470970-96470971 | Flanking Active TSS Enhancers Weak transcription Active TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs144017556 | chr9:96471042-96471043 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs548699287 | chr9:96471068-96471069 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs570083174 | chr9:96471076-96471077 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs190790035 | chr9:96471096-96471097 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs146613749 | chr9:96471138-96471139 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs116554110 | chr9:96471148-96471149 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs116114615 | chr9:96471162-96471163 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs553689727 | chr9:96471169-96471170 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs181746073 | chr9:96471236-96471237 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs76191882 | chr9:96471240-96471241 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
26 | rs28405578 | chr9:96471242-96471243 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
27 | rs7874508 | chr9:96471252-96471253 | Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs374383223 | chr9:96471282-96471283 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs7874616 | chr9:96471340-96471341 | Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Medulloblastoma | 21979893 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 16751803 | CNVD |
Myelofibrosis | 22110671 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Leukemia | 17361228 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Glioblastoma | 16823260 | CNVD |
Leukemia | 18688285 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Brain cancer | 20823417 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Heart disease | 21282601 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Lung cancer | 18438408 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Oral cancer | 21386901 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Wilms tumour | 21544195 | CNVD |
Prostate cancer | 18632612 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Gastric cancer | 17908304 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Biliary cancer | 19435499 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Cardiac fibroma | 18329553 | CNVD |
Mental retardation | 21693067 | CNVD |
Breast cancer | 17133270 | CNVD |
Basal cell nevus syndrome | 21572526 | CNVD |
Mental retardation | 19951919 | CNVD |
Retinoblastoma | 22278416 | CNVD |
9q22.3 microdeletion syndrome | 22283845 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Microcephaly | 18830227 | CNVD |
overgrowth syndrome | 16570072 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:96469800-96470600 | Active TSS | Skeletal Muscle Female | skeletal muscle |
2 | chr9:96470400-96470800 | Enhancers | Fetal Muscle Leg | muscle |
3 | chr9:96470400-96471000 | Weak transcription | Right Atrium | heart |
4 | chr9:96470600-96471000 | Active TSS | Skeletal Muscle Male | skeletal muscle |
5 | chr9:96470600-96471400 | Enhancers | Fetal Stomach | stomach |
6 | chr9:96470600-96471400 | Flanking Active TSS | Skeletal Muscle Female | skeletal muscle |
7 | chr9:96470600-96473000 | Enhancers | Stomach Smooth Muscle | stomach |
8 | chr9:96470800-96471000 | Flanking Active TSS | Fetal Muscle Leg | muscle |
9 | chr9:96470800-96471400 | Enhancers | Psoas Muscle | Psoas |
10 | chr9:96471000-96471400 | Enhancers | Right Atrium | heart |
11 | chr9:96471000-96471400 | Flanking Active TSS | Skeletal Muscle Male | skeletal muscle |
12 | chr9:96471000-96471800 | Enhancers | Fetal Muscle Leg | muscle |